DE69025967T2 - Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen - Google Patents

Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen

Info

Publication number
DE69025967T2
DE69025967T2 DE69025967T DE69025967T DE69025967T2 DE 69025967 T2 DE69025967 T2 DE 69025967T2 DE 69025967 T DE69025967 T DE 69025967T DE 69025967 T DE69025967 T DE 69025967T DE 69025967 T2 DE69025967 T2 DE 69025967T2
Authority
DE
Germany
Prior art keywords
interleukin
pyrrole
heteroaryl
aryl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69025967T
Other languages
English (en)
Other versions
DE69025967D1 (de
Inventor
Roger A Parker
George Ku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69025967D1 publication Critical patent/DE69025967D1/de
Application granted granted Critical
Publication of DE69025967T2 publication Critical patent/DE69025967T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
DE69025967T 1989-01-31 1990-01-30 Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen Expired - Fee Related DE69025967T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30414189A 1989-01-31 1989-01-31

Publications (2)

Publication Number Publication Date
DE69025967D1 DE69025967D1 (de) 1996-04-25
DE69025967T2 true DE69025967T2 (de) 1996-08-29

Family

ID=23175237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69025967T Expired - Fee Related DE69025967T2 (de) 1989-01-31 1990-01-30 Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen

Country Status (17)

Country Link
EP (1) EP0381141B1 (de)
JP (1) JP2841305B2 (de)
KR (1) KR0139288B1 (de)
CN (1) CN1022754C (de)
AR (1) AR245694A1 (de)
AT (1) ATE135702T1 (de)
AU (1) AU629290B2 (de)
CA (1) CA2008616C (de)
DE (1) DE69025967T2 (de)
ES (1) ES2087093T3 (de)
FI (1) FI900464A0 (de)
HU (1) HU209290B (de)
IL (1) IL93187A (de)
NO (1) NO174887C (de)
NZ (1) NZ232278A (de)
PT (1) PT93009A (de)
ZA (1) ZA90554B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
ZA90555B (en) * 1989-01-31 1990-10-31 Merrell Pharma Inc Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
CN102548964B (zh) 2009-07-10 2014-09-24 通用医疗公司 不抑制肾上腺皮质类固醇合成的依托咪酯类似物
CN102114430B (zh) * 2009-12-30 2013-06-05 上海睿智化学研究有限公司 催化剂、其制备方法及n-烷基吡咯衍生物的制备方法
SI2802325T1 (sl) 2012-01-13 2017-04-26 The General Hospital Corporation Anestetične spojine in pripadajoči postopki za uporabo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112112A (en) * 1976-06-29 1978-09-05 Merck & Co., Inc. Pyrrolo[2,1-b] [3]benzazepines useful for producing a skeletal muscle relaxing or tranquilizing effect
JPS54128567A (en) * 1978-03-28 1979-10-05 Teijin Ltd 1-substituted-4-acyl-2-pyrrolecarboxylic acid derivative

Also Published As

Publication number Publication date
ES2087093T3 (es) 1996-07-16
NO174887C (no) 1994-07-27
DE69025967D1 (de) 1996-04-25
HUT53868A (en) 1990-12-28
JPH02247165A (ja) 1990-10-02
NO900432D0 (no) 1990-01-30
NO174887B (no) 1994-04-18
KR900011725A (ko) 1990-08-02
IL93187A0 (en) 1990-11-05
AR245694A1 (es) 1994-02-28
IL93187A (en) 1994-12-29
NO900432L (no) 1990-08-01
ZA90554B (en) 1990-10-31
CA2008616C (en) 2000-07-18
EP0381141A3 (de) 1991-11-21
CN1044653A (zh) 1990-08-15
HU900592D0 (en) 1990-04-28
EP0381141A2 (de) 1990-08-08
PT93009A (pt) 1990-07-31
CA2008616A1 (en) 1990-07-31
NZ232278A (en) 1992-07-28
AU629290B2 (en) 1992-10-01
EP0381141B1 (de) 1996-03-20
ATE135702T1 (de) 1996-04-15
AU4875990A (en) 1990-08-09
HU209290B (en) 1994-04-28
KR0139288B1 (ko) 1998-05-15
FI900464A0 (fi) 1990-01-30
JP2841305B2 (ja) 1998-12-24
CN1022754C (zh) 1993-11-17

Similar Documents

Publication Publication Date Title
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
DE69004081T2 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE3888056T2 (de) Oxadiazolyl-azabicycloheptane zur Behandlung von seniler Demenz.
DE3782028T2 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE3785530T2 (de) Verfahren zur Herstellung von L-Arginin.
DE3879049T2 (de) Verfahren zur Herstellung von Penizillan-Säurederivaten.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DE59004490D1 (de) Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten.
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
DE68907386T2 (de) Verwendung von Phytinsäure oder deren Salzen zur Verhinderung oder Behandlung von Lebererkrankungen.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ZA91762B (en) Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE59007538D1 (de) Verfahren zur Behandlung von gewalzten Bändern.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE59007620D1 (de) Verfahren zur Herstellung von 3-Methylchinolin-8-carbonsäure.
DE68907972T2 (de) Verfahren zur Herstellung von L-Arginin.
DE69020372T2 (de) Verfahren zur Herstellung von Aminothiazolylessigsäure-Derivate.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
DE68915904T2 (de) Verfahren zur Herstellung von Para-bromphenoxyacetaldehyd-dialkylacetal-Derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee